Filing metadata

Accession number
0001104659-21-154397
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Dec 29, 2021
Reporting period
Dec 28, 2021
Description
Insider transaction

Explore SEC Filings Hub